Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
If you want the full 14-section dosing, titration, and reconstitution breakdown for any single compound, use the individual protocol links throughout this page
"I tried everything for knee pain, and nothing worked until this
With the 10mg/ml concentration, a 1.25mg dose equals 12.5 units
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
Many researchers wonder about overall timelines , and the answer depends heavily on proper dose escalation through each phase
